Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000 liters Plant 4's total capacity of 240,000 liters to be ready early next year INCHEON, South Korea, Oct. 11, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that...
HanAll’s Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab
Harbour BioMed, HanAll's licensed partner in China, signed a sublicense agreement with CSPC NBP Pharmaceutical for batoclimab, an FcRn compound originally discovered and developed by HanAll Biopharma Batoclimab is one of the most advanced FcRn inhibitors being developed in Greater China, with the potential of becoming the first-in-FcRn class therapy to...
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder
PHILADELPHIA and SAN JOSE, Calif. and NANJING and SHANGHAI, China, Oct. 11, 2022 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative medicines and Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced...
Integrating Fitbit & MindFi App into Daily Lifestyle Leads to Significant Improvements in Teachers’ Mental Wellness – Singapore Study
SINGAPORE, Oct. 11, 2022 /PRNewswire/ -- Regular use of a mental wellness app solution combined with Fitbit wearable devices to track activity and sleep can have a positive impact on users' physical and mental health, according to a new pilot study involving Singapore teachers. After a challenging time for teachers which saw working...
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days to 150 days LEIDEN, Netherlands, Oct. 11, 2022 /PRNewswire/ -- Pharming...
The Asia Pacific Enterprise Awards 2022 Vietnam Honors Business Leaders and Enterprises Spearheading Vietnam’s Exceptional Growth
SINGAPORE, Oct. 10, 2022 /PRNewswire/ -- 88 outstanding business leaders and enterprises were recognized for their commendable dedication toward accelerating Vietnam's development at the Asia Pacific Enterprise Awards 2022 Vietnam Chapter. The Awards were presented by Enterprise Asia, the leading regional non-governmental organization for entrepreneurship. The award recipients were selected from over 300 nominees through a rigorous evaluation process...
Waterdrop Inc. CEO Shen Peng Attends Future China Global Forum 2022
BEIJING, Oct. 10, 2022 /PRNewswire/ -- On October 7, 2022, the Future China Global Forum 2022 was held in Singapore. Mr. Peng Shen, Founder and CEO of Waterdrop, attended the forum via video link and introduced the Company's operations in Singapore. Initiated by Singapore's former prime minister Mr. Lee Kuan Yew in 2010, the Future China Global Forum is...
Translumina further strengthens senior leadership to drive next phase of growth
NEW DELHI, Oct. 10, 2022 /PRNewswire/ -- Translumina - a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products - appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the company's Europe operations. Indranil is a veteran in the healthcare...
MAYBELLINE NY LAUNCHES FREE MENTAL HEALTH TRAINING IN COLLEGES
Brave Talk is a global college training program designed in partnership with mental health experts to give students the tools to support those around them experiencing anxiety or depression NEW YORK, Oct. 10, 2022 /PRNewswire/ -- More than half of first-year college students (54%) frequently felt anxious since starting college – and...
Actinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer’s Disease (AD) patients
Clinical Dementia Rating Scale - Sum of Boxes effect of 0.6 to 0.8 points observed in patients with elevated pTau biomarker with once daily, 10 mg, oral therapy SYDNEY, Oct. 10, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) today announces positive Phase 2a clinical data from its Alzheimer's Disease (AD) biomarker study, which validates the Company's planned Xanamem program...












